Concepedia

Gentry Teng King

GT

Statistics

Publications

6

Citations

221

H-Index

6

Active since

2009

Affiliations

University of Washington(Current)

University of Washington Medical Center

University of Colorado Denver

Fred Hutch Cancer Center

University of Colorado Cancer Center

Gentry Teng King is an author at University of Washington specializing in pathology, oncology, and medicine.

ORCID

Top concepts

Publications per year

2009–2024

6

Publications

6

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

Gentry Teng King, Keith D. Eaton, Brandon Beagle et al. · Investigational New Drugs · 2018 · 86 citations · Full text

, , +7

Central nervous system infections in Filipino patients with systemic lupus erythematosus

Pauline Jea VARGAS, Gentry Teng King, Sandra Navarra · International Journal of Rheumatic Diseases · 2009 · 37 citations

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Rachna T. Shroff, Gentry Teng King, Sarah Colby et al. · Journal of Clinical Oncology · 2024 · 33 citations · Full text

<i>KRAS</i>Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

Adam Diehl, Lindsay M. Hannan, David B. Zhen et al. · The Oncologist · 2022 · 29 citations · Full text

Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study

Atsushi Oba, Yan‐Dong Wu, Christopher H. Lieu et al. · British journal of surgery · 2021 · 20 citations

1–5 of 6